Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer-Reference-Cited by-同舟云学术

Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer

Published:2016-02-09 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Sansone Pasquale,Ceccarelli Claudio,Berishaj Marjan,Chang Qing,Rajasekhar Vinagolu K.,Perna Fabiana,Bowman Robert L.,Vidone Michele,Daly Laura,Nnoli Jennifer,Santini Donatella,Taffurelli Mario,Shih Natalie N. C.,Feldman Michael,Mao Jun J.,Colameco Christopher,Chen Jinbo,DeMichele Angela,Fabbri Nicola,Healey John H.,Cricca Monica,Gasparre Giuseppe,Lyden David,Bonafé Massimiliano,Bromberg Jacqueline

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms10442.pdf

Reference27 articles.

1. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumourigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003) .

2. Korkaya, H. et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 47, 570–584 (2012) .

3. Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62–73 (2010) .

4. Hwang-Verslues, W. W. et al. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE 4, e8377 (2009) .

5. Shipitsin, M. et al. Molecular definition of breast tumour heterogeneity. Cancer Cell 11, 259–273 (2007) .

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrimidine–triazole‐tethered tert‐butyl‐piperazine‐carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β‐catenin activation;IUBMB Life;2024-09-14

2. Obesity, dysbiosis and inflammation: interactions that modulate the efficacy of immunotherapy;Frontiers in Immunology;2024-08-26

3. Tumor‐Specific Nano‐Herb Delivery System with High L‐Arginine Loading for Synergistic Chemo and Gas Therapy against Cervical Cancer;Small;2024-08-05

4. HOXC11-mediated regulation of mitochondrial function modulates chemoresistance in colorectal cancer;BMC Cancer;2024-07-30

5. Effective exosomes in breast cancer: focusing on diagnosis and treatment of cancer progression;Pathology - Research and Practice;2024-01